Filtered By:
Specialty: Primary Care
Condition: Thrombosis

This page shows you your search results in order of date. This is page number 3.

Order by Relevance | Date

Total 33 results found since Jan 2013.

Stroke: Initiative Cuts Time to tPA (CME/CE)
SAN DIEGO (MedPage Today) -- An effort to shorten the time between when patients with acute ischemic stroke arrive at the hospital and when they receive intravenous thrombolytic therapy -- the door-to-needle time -- proved successful, researchers found.
Source: MedPage Today Primary Care - February 17, 2014 Category: Primary Care Source Type: news

The change of paradigm in stroke prevention in atrial fibrillation. Challenges and emerging opportunities for the family physician.
Abstract Atrial fibrillation (AF), is the most prevalent sustained arrhythmia in general population, affecting up to 10% in patients of advanced age. AF doubles overall mortality and increases up to 5-6 times the risk of stroke, which have the characteristic of being particularly harmfull. The basis of treatment on AF are the rhythm or rate control and the prevention of thromboembolism. For the latter purpose the treatments that have been most effective are oral acticoagulants. For decades and until just a few years ago, the only oral drugs available for this purpose have been the anti-vitamin K, mainly represente...
Source: Atencion Primaria - April 1, 2013 Category: Primary Care Authors: Castillo Rodríguez JC, Lozano IF Tags: Aten Primaria Source Type: research

Combined hormonal contraception
Abstract: Combined oral contraception is now available as oral, transdermal, vaginal and injectable preparations. Only the pill and patch are currently marketed in the UK. Most of the data come from the oral preparation (the combined pill), which has been marketed for more than 40 years and used by millions of women. Used perfectly, combined hormonal contraception is highly effective (failure rate 1/1000), because it works by inhibiting ovulation. In typical use, however, mistakes are made, and pill failure rates are about 8%. Serious cardiovascular side-effects (heart attack, stroke and venous thromboembolism) are ra...
Source: Women's Health Medicine - November 1, 2006 Category: Primary Care Authors: Anna Glasier Source Type: research